Creative Medical TechnologyCELZ
13F holders, Q1 2026 (March 31)11holders −3
4new positions
6sold out
$2.06avg. 13F price*
At the end of Q1 2026, 11 institutions reported holding Creative Medical Technology (CELZ) in their 13F filings, down 3 from Q4 2025. 4 opened new positions and 6 sold out. The largest holders were Geode Capital Management, LLC ($79K), Vanguard Capital Management LLC ($42K) and XTX Topco Ltd ($29K).
- Company
- Creative Medical Technology
- CUSIP
- 22529Y408
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $62K |
| Exits | 6 | $126K |
All 13F filers, Q4 2025 → Q1 2026: 40,302 shares bought and 64,480 shares sold, net −24,178 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 11 holders
| Geode Capital Management, LLC | 0.00% | Add +34.5% | 38,290 | $79K |
| Vanguard Capital Management LLC | 0.00% | — | 20,350 | $42K |
| XTX Topco Ltd | 0.00% | New | 14,260 | $29K |
| Susquehanna International Group, LLP | 0.00% | New | 10,469 | $22K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 5,518 | $11K |
| Wells Fargo & Company | 0.00% | New | 5,000 | $10K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -9.6% | 2,092 | $4K |
| Morgan Stanley | 0.00% | Add +1470.6% | 534 | $1K |
| FMR LLC | 0.00% | New | 250 | $515 |
| UBS Group AG | 0.00% | Reduce -90.9% | 1 | $2 |
| SBI Securities Co., Ltd. | 0.00% | No change | 1 | $2 |
"% of holder's portfolio" is CELZ's weight in each manager's 13F, not the share of Creative Medical Technology the manager owns.